目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY STEPS
FIGURE 1 RESEARCH METHODOLOGY: REMOTE PATIENT MONITORING MARKET
FIGURE 2 RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Breakdown of primary sources
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 6 ESTIMATION OF THE MARKET SIZE FOR REMOTE PATIENT MONITORING SOFTWARE & SERVICES THROUGH THE ADOPTION-BASED APPROACH
FIGURE 7 ESTIMATION OF THE GLOBAL REMOTE PATIENT MONITORING MARKET SIZE THROUGH THE ADOPTION-BASED APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19-SPECIFIC ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS

3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 9 REMOTE PATIENT MONITORING MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 REMOTE PATIENT MONITORING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE REMOTE PATIENT MONITORING MARKET

4 PREMIUM INSIGHTS (Page No. - 47)
4.1 REMOTE PATIENT MONITORING: MARKET OVERVIEW
FIGURE 12 COST BENEFITS OF TELEHEALTH & TELEMEDICINE COUPLED WITH THE RISING TECHNOLOGICAL ADVANCEMENTS IN REMOTE PATIENT MONITORING DEVICES ARE THE KEY GROWTH DRIVERS FOR THIS MARKET
4.2 REMOTE PATIENT MONITORING MARKET, BY END USER
FIGURE 13 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE RPM MARKET IN 2021
4.3 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY PRODUCT & COUNTRY (2021)
FIGURE 14 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN NORTH AMERICA FOR REMOTE PATIENT MONITORING IN 2021
4.4 GEOGRAPHICAL SNAPSHOT OF THE REMOTE PATIENT MONITORING MARKET
FIGURE 15 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 50)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising geriatric population and the growing need to expand healthcare access
TABLE 2 GLOBAL OVERVIEW OF THE RISE IN AGING POPULATION (MILLION)
5.2.1.2 Cost benefits of telehealth and remote patient monitoring
TABLE 3 CHRONIC DISEASES AND COST BURDEN IN THE US: POTENTIAL FOR SAVINGS (2020)
5.2.1.3 Benefits of RPM to reduce the burden on medical resources
5.2.1.4 Advancements in telecommunications
5.2.1.5 Increasing investments in telehealth & RPM
5.2.2 RESTRAINTS
5.2.2.1 Regulatory variations across regions
TABLE 4 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH
5.2.2.2 Healthcare fraud
5.2.2.3 Informal usage of social media practices
5.2.3 OPPORTUNITIES
5.2.3.1 Role and impact of AI in remote patient monitoring
5.2.3.2 High utility of RPM in combating infectious diseases & epidemics
5.2.3.3 Significant opportunities in data monetization of patient data
5.2.4 CHALLENGES
5.2.4.1 Data privacy concerns, healthcare affordability, and limited awareness
5.2.4.2 Data accessibility issues
5.3 IMPACT OF COVID-19 ON THE REMOTE PATIENT MONITORING MARKET
5.4 PRICING AND REIMBURSEMENT ANALYSIS
TABLE 5 CPT CDES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET
5.5 VALUE CHAIN ANALYSIS
FIGURE 17 REMOTE PATIENT MONITORING MARKET: VALUE CHAIN
5.6 ECOSYSTEM ANALYSIS
FIGURE 18 REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
5.7 TECHNOLOGY ANALYSIS
TABLE 6 DIGITAL TECHNOLOGY ENABLERS: BENEFITS AND EXAMPLES IN THE REMOTE PATIENT MONITORING MARKET
5.8 END-USER ASSESSMENT OF RPM MARKET: US
5.8.1 DIGITAL TECHNOLOGY ENABLERS: BENEFITS AND EXAMPLES IN THE REMOTE PATIENT MONITORING MARKET
TABLE 7 ADOPTION OF REMOTE PATIENT MONITORING AMONG END-USERS IN US (%)
5.9 REMOTE PATIENT MONITORING MARKET: PREVALENT SALES CHANNELS
FIGURE 19 COMMERCIALISATION STRATEGIES
5.10 KEY INDUSTRY TRENDS
5.11 OVERVIEW OF USE CASES
TABLE 8 REMOTE PATIENT MONITORING USE CASES
TABLE 9 BASIC AND ADVANCED CAPABILITIES OF RPM SERVICES
5.12 INTRODUCTION
TABLE 10 REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
5.13 SOFTWARE AND SERVICES
5.13.1 CONVENIENCE AND THE HIGH UTILITY OF RPM ARE THE KEY FACTORS DRIVING THE DEMAND FOR REMOTE MONITORING SOFTWARE & SERVICES
TABLE 11 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 12 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 13 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.14 DEVICES
TABLE 14 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 15 REMOTE PATIENT MONITORING MARKET FOR DEVICES, 2020-2027 (USD MILLION)
TABLE 16 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 17 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.14.1 CARDIAC MONITORING DEVICES
5.14.1.1 The rising incidence of cardiovascular diseases drives the demand for ECG monitors, thus, driving the market growth in this segment
TABLE 18 REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 19 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 21 REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2020-2027 (USD MILLION)
5.14.2 BLOOD PRESSURE MONITORING DEVICES
5.14.2.1 Convenience and the growing demand for blood pressure meters have ensured high market growth in this segment
TABLE 22 REMOTE PATIENT MONITORING MARKET FOR BLOOD PRESSURE MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
5.14.3 NEUROLOGICAL MONITORING DEVICES
5.14.3.1 Growing prevalence of neurological diseases to drive the growth of this segment
TABLE 23 REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 24 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 25 EUROPE: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.14.4 RESPIRATORY MONITORING DEVICES
5.14.4.1 The growing adoption of pulse oximeters for self-monitoring during the COVID-19 pandemic is a key factor driving the market growth of this segment
TABLE 26 REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 27 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 28 EUROPE: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.14.5 MULTIPARAMETER MONITORING DEVICES
5.14.5.1 The increasing prevalence of chronic diseases is a major factor driving the market growth for this segment
TABLE 29 REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 30 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 31 EUROPE: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.14.6 BLOOD GLUCOSE MONITORING DEVICES
5.14.6.1 Growth in the global diabetic population will ensure a strong demand for blood glucose monitoring devices
TABLE 32 REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 33 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 34 EUROPE: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.14.7 FETAL & NEONATAL MONITORING DEVICES
5.14.7.1 Rising number of preterm births globally, to ensure the strong demand for RPM solutions in this segment
TABLE 35 REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 36 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 37 EUROPE: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.14.8 WEIGHT MONITORING DEVICES
5.14.8.1 Rising obesity levels ensure a strong demand for weight monitoring devices, thus driving the market growth for this segment
TABLE 38 REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 39 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 40 EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.14.9 OTHER MONITORING DEVICES
TABLE 41 REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY REGION, 2020-2027 (USD MILLION)
TABLE 42 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 43 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
5.15 INTRODUCTION
TABLE 44 REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
5.16 PROVIDERS
TABLE 45 REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 46 REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY REGION, 2020-2027 (USD MILLION)
TABLE 47 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 48 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2020-2027 (USD MILLION)
5.16.1 HOSPITALS AND CLINICS
5.16.1.1 Hospitals and clinics contribute to the highest share of the providers market in the remote patient monitoring market in 2021
TABLE 49 REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2027 (USD MILLION)
TABLE 50 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 51 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
5.16.2 HOME CARE SETTINGS AND LONG-TERM CARE CENTERS
5.16.2.1 A rise in the global geriatric population requiring long-term care to support the growth of this end-user segment
TABLE 52 REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY REGION, 2020-2027 (USD MILLION)
TABLE 53 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 54 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
5.16.3 AMBULATORY CARE CENTRES
5.16.3.1 The gradual shift of patient care from inpatient to outpatient settings drives the growth of this end-user segment
TABLE 55 REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020-2027 (USD MILLION)
TABLE 56 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 57 EUROPE: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
5.16.4 OTHER PROVIDERS
TABLE 58 REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY REGION, 2020-2027 (USD MILLION)
TABLE 59 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 60 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2020-2027 (USD MILLION)
5.17 PAYERS
5.17.1 INCREASING REIMBURSEMENTS FOR REMOTE PATIENT MONITORING TO DRIVE THE SEGMENT GROWTH
TABLE 61 REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY REGION, 2020-2027 (USD MILLION)
TABLE 62 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 63 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2020-2027 (USD MILLION)
5.18 PATIENTS
5.18.1 COST-BENEFITS AND THE EMERGENCE OF ADVANCED WEARABLE MONITORS TO SUPPORT THE DEMAND FOR RPM DEVICES AMONG PATIENTS
TABLE 64 REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2020-2027 (USD MILLION)
TABLE 65 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 66 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2020-2027 (USD MILLION)
5.18.2 OTHER END USERS
TABLE 67 REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)
TABLE 68 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 69 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)

6 REMOTE PATIENT MONITORING MARKET, BY REGION (Page No. - 105)
6.1 INTRODUCTION
TABLE 70 REMOTE PATIENT MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
6.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT
TABLE 71 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 72 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 73 NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 74 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 75 NORTH AMERICA: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.2.1 US
6.2.1.1 The US accounted for the largest share of the North American market in 2021
TABLE 76 US: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 77 US: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 78 US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 79 US: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.2.2 CANADA
6.2.2.1 The increasing rate of cardiac diseases promotes the adoption of RPM solutions, thus supplementing the market growth in Canada
TABLE 80 CANADA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 81 CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 82 CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 83 CANADA: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.3 EUROPE
FIGURE 21 EUROPE: REMOTE PATIENT MONITORING MARKET SNAPSHOT
TABLE 84 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 85 EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 86 EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 87 EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 88 EUROPE: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.3.1 GERMANY
6.3.1.1 Rapid digitization of healthcare systems and the rise in the geriatric population are key factors driving the market growth in Germany
TABLE 89 GERMANY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 90 GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 91 GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 92 GERMANY: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.3.2 FRANCE
6.3.2.1 Favorable reimbursements and investments for telehealth is expected to support the market growth in France
TABLE 93 FRANCE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 94 FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 95 FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 96 FRANCE: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.3.3 UK
6.3.3.1 The increasing need to manage healthcare expenditure and a severe shortage of physicians has boosted the adoption of telehealth in the UK
TABLE 97 UK: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 98 UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 99 UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 100 UK: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.3.4 ITALY
6.3.4.1 Established telehealth practices and a high density of elderly people in Italy is expected to drive the demand for RPM solutions
TABLE 101 ITALY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 102 ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 103 ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 104 ITALY: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.3.5 SPAIN
6.3.5.1 A well-organized healthcare system indicates growing opportunities for the adoption of telehealth solutions in Spain
TABLE 105 SPAIN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 106 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 107 SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 108 SPAIN: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.3.6 REST OF EUROPE (ROE)
TABLE 109 ROE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 110 ROE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 111 ROE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 112 ROE: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.4 ASIA PACIFIC
TABLE 113 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 114 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 115 ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 116 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 117 ASIA PACIFIC: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.4.1 CHINA
6.4.1.1 China shows significant growth opportunities for advanced internet-based platforms in the RPM market
TABLE 118 CHINA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 119 CHINA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 120 CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 121 CHINA: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.4.2 JAPAN
6.4.2.1 Universal healthcare coverage and an established insurance system makes Japan a prominent market for RPM services
TABLE 122 JAPAN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 123 JAPAN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 124 JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 125 JAPAN: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.4.3 INDIA
6.4.3.1 Favorable government policies and the high density of population in rural areas support the market growth for RPM solutions in India
TABLE 126 INDIA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 127 INDIA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 128 INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 129 INDIA: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 130 ROAPAC: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 131 ROAPAC: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 132 ROAPAC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 133 ROAPAC: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.5 LATIN AMERICA
TABLE 134 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 135 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 136 LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 137 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 138 LATIN AMERICA: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.5.1 BRAZIL
6.5.1.1 Restricting informal consultations on social media to drive the market growth of RPM services in Brazil
TABLE 139 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 140 BRAZIL: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 141 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 142 BRAZIL: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.5.2 MEXICO
6.5.2.1 Increasing government initiatives to improve healthcare infrastructure in Mexico, thus driving the adoption of telehealth solutions
TABLE 143 MEXICO: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 144 MEXICO: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 145 MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 146 MEXICO: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.5.3 REST OF LATIN AMERICA (ROLATAM)
TABLE 147 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 148 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 149 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 150 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.5.4 MIDDLE EAST & AFRICA
6.5.4.1 Healthcare infrastructural development and rising government initiatives for the adoption of RPM to drive the market growth in this region
TABLE 151 MIDDLE EAST AND AFRICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA: REMOTE PATIENT MONITORING FOR THE PROVIDERS MARKET, BY TYPE, 2020-2027 (USD MILLION)

7 COMPETITIVE LANDSCAPE (Page No. - 153)
7.1 OVERVIEW
FIGURE 22 THE KEY PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN 2018 AND 2021
7.2 MARKET RANKING ANALYSIS, 2021
FIGURE 23 REMOTE PATIENT MONITORING MARKET, BY KEY PLAYER, 2021
7.3 COMPETITIVE SCENARIO
7.3.1 DEALS
7.3.2 PRODUCT LAUNCHES
7.3.3 OTHER DEVELOPMENTS

8 COMPANY EVALUATION MATRIX (Page No. - 157)
8.1 INTRODUCTION
8.2 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
TABLE 155 COMPANY EVALUATION MATRIX: CRITERIA
8.2.1 STARS
8.2.2 EMERGING LEADERS
8.2.3 PERVASIVE PLAYERS
8.2.4 EMERGING COMPANIES
FIGURE 24 MNM VENDOR DIVE COMPARISON MATRIX: REMOTE PATIENT MONITORING MARKET
8.3 COMPANY EVALUATION QUADRANT FOR START-UPS
8.3.1 PROGRESSIVE COMPANIES
8.3.2 DYNAMIC COMPANIES
8.3.3 STARTING BLOCKS
8.3.4 RESPONSIVE COMPANIES
FIGURE 25 COMPANY EVALUATION QUADRANT FOR START-UPS: REMOTE PATIENT MONITORING MARKET
8.4 COMPETITIVE BENCHMARKING
8.4.1 COMPANY PRODUCT FOOTPRINT
TABLE 156 COMPANY PRODUCT FOOTPRINT
8.4.2 COMPANY REGION FOOTPRINT
TABLE 157 COMPANY REGION FOOTPRINT

9 COMPANY PROFILES (Page No. - 164)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 KONINKLIJKE PHILIPS
FIGURE 26 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2020)
9.2 MEDTRONIC
FIGURE 27 MEDTRONIC: COMPANY SNAPSHOT (2020)
9.3 OMRON HEALTHCARE INC. (A PART OF OMRON CORPORATION)
FIGURE 28 OMRON CORPORATION: COMPANY SNAPSHOT (2020)
9.4 GE HEALTHCARE
FIGURE 29 GE HEALTHCARE: COMPANY SNAPSHOT (2020)
9.5 CERNER CORPORATION
FIGURE 30 CERNER CORPORATION: COMPANY SNAPSHOT (2020)
9.6 SIEMENS HEALTHINEERS AG
FIGURE 31 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
9.7 BOSTON SCIENTIFIC CORPORATION
FIGURE 32 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
9.8 ABBOTT LABORATORIES
FIGURE 33 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
9.9 ALTEN CALSOFT LABS (A SUBSIDIARY OF ALTEN GROUP)
FIGURE 34 ALTEN GROUP: COMPANY SNAPSHOT (2020)
9.10 RESIDEO LIFE CARE SOLUTIONS
9.11 VIVIFY HEALTH, INC.
9.12 PREVENTICE SOLUTIONS
9.13 BIO-BEAT TECHNOLOGIES
9.14 VITALCONNECT
9.15 OTHER PLAYERS
9.15.1 WELCH ALLYN (A SUBSIDIARY OF HILL ROM SERVICES, INC.)
9.15.2 TELEDOC HEALTH INC.
9.15.3 DEXCOM, INC.
9.15.4 IRHYTHM TECHNOLOGIES
9.15.5 VIVALNK INC
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

10 APPENDIX (Page No. - 201)
10.1 DISCUSSION GUIDE
10.2 AVAILABLE CUSTOMIZATIONS
10.3 RELATED REPORTS
10.4 AUTHOR DETAILS